Quantitative chemical proteomics for identifying candidate drug targets

Analytical Chemistry

Volumn 75, Issue 9, 2003, Pages 2159-2165

  Oda, Yoshiya ^a   Owa, Takashi ^a   Sato, Toshitaka ^a   Boucher, Brian ^b   Daniels, Scott ^b   Yamanaka, Hidenori ^c   Shinohara, Yasuhiro ^c   Yokoi, Akira ^a   Kuromitsu, Junro ^a   Nagasu, Takeshi ^a  

^a EISAI CO LTD   (Japan)

^b Applied Biosystems Framingham   (United States)

^c Amersham Biosciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPOSITION; ISOTOPES; LIQUID CHROMATOGRAPHY; PROTEINS; TUMORS;

PROTEOLYSIS;

DRUG PRODUCTS;

ANTINEOPLASTIC AGENT;

ARTICLE; BINDING AFFINITY; CHEMICAL STRUCTURE; DRUG ACTIVITY; DRUG TARGETING; GENETIC TRANSCRIPTION; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN ISOLATION; PROTEOMICS; QUANTITATIVE ANALYSIS; STRUCTURE ACTIVITY RELATION; SURFACE PLASMON RESONANCE;

ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOMICS; SULFONAMIDES; SURFACE PLASMON RESONANCE; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0038371369     PISSN: 00032700     EISSN: None     Source Type: Journal    
DOI: 10.1021/ac026196y     Document Type: Article

References (23)

1. Drews, J. Science 2000, 287, 1960-1964.
2. Haggarty, S. J.; Mayer, T. U.; Miyamoto, D. T.; Fathi, R.; King, R. W.; Mitchison, T. J.; Schreiber, S. L. Chem. Biol. 2000, 7, 275-286.
3. Stockwell, B. R. Trends Biotechnol. 2000, 18, 449-455.
4. Harding, M. W.; Galat, A.; Uehling, D. E.; Schreiber, S. L. Nature 1989, 341, 758-760.
5. Taunton, J.; Hassig, C. A.; Schreiber, S. L. Science 1996, 272, 408-411.
6. Unlu, M.; Morgan, M. E.; Minden, J. S. Electrophoresis 1997, 18, 2071-2077.
7. Owa, T.; Yoshino, H.; Okauchi, T.; Yoshimatsu, K.; Ozawa, Y.; Sugi, N. H.; Nagasu, T.; Koyanagi, N.; Kitoh, K. J. Med. Chem. 1999, 42, 3789-3799.
8. Owa, T.; Yoshino, H.; Yoshimatsu, K.; Nagasu, T. Curr. Med. Chem. 2001, 8, 1487-1503.
9. Yokoi, A.; Kuromitsu, J.; Kawai, T.; Nagasu, T.; Sugi, N. H.; Yoshimatsu, K; Yoshino, H.; Owa, T. Mol. Cancer Ther. 2002, 1, 275-286.
10. Mosmann, T. J. Immunol. Methods 1983, 65, 55-63.
11. Katayama, H.; Nagasu, T.; Oda, Y. Rapid Commun. Mass Spectrom. 2001, 15, 1416-1421.
12. Lockhart, D. J.; Dong, H.; Byrne, M. C.; Follettie, M. T.; Gallo, M. V.; Chee, M. S.; Mittmann, M.; Wang, C.; Kobayashi, M.; Horton, H.; Brown, E. L. Nat. Biotechnol. 1996, 14, 1675-1680.
13. Shimizu, N.; Sugimoto, K.; Tang, J.; Nishi, T.; Sato, I.; Hiramoto, M.; Aizawa, S.; Hatakeyama, M.; Ohba, R.; Hatori, H.; Yoshikawa, T.; Suzuki, F.; Oomori, A.; Tanaka, H.; Kawaguchi, H.; Watanabe, H.; Handa, H. Nat. Biotechnol. 2000, 18, 877-881.
14. Link, A. J.; Eng, J.; Schieltz, D. M.; Carmack, E.; Mize, G. J.; Morris, D. R.; Garvik, B. M.; Yates, J. R., 3rd. Nat. Biotechnol. 1999, 17, 676-682.
15. Washburn, M. P.; Wolters, D.; Yates, J. R., 3rd. Nat. Biotechnol. 2001, 19, 242-247.
16. Gygi, S. P.; Corthals, G. L.; Zhang, Y.; Rochon, Y.; Aebersold, R. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 9390-9395.
17. Gygi, S. P.; Rist, B.; Gerber, S. A.; Turecek, F.; Gelb, M. H.; Aebersold, R. Nat. Biotechnol. 1999, 17, 994-999.
18. Han, D. K.; Eng, J.; Zhou, H.; Aebersold, R. Nat. Biotechnol. 2001, 19, 946-951.
19. Zhou, H.; Ranish, J. A.; Watts, J. D.; Aebersold, R. Nat. Biotechnol. 2002, 20, 512-515.
20. Owa, T.; Yokoi, A.; Yamazaki, K.; Yoshimatsu, K.; Yamori, T.; Nagasu, T. J. Med. Chem. 2002, 45, 4913-4922.
21. Burgos, C.; Gerez de Burgos, N. M.; Rovai, L. E.; Blanco, A. Biochem. Pharmacol. 1986, 35, 801-804.
22. Knockaert, M.; Meijer, L. Biochem. Pharmacol. 2002, 64, 819-825.
23. Knockaert, M.; Wieking, K.; Schmitt, S.; Leost, M.; Grant, K. M.; Mottram, J. C.; Kunick, C.; Meijer, L. J. Biol. Chem. 2002, 277, 25493-25501.